221 related articles for article (PubMed ID: 8808494)
1. The resistance of low density lipoprotein to oxidation promoted by copper and its use as an index of antioxidant therapy.
O'Leary VJ; Tilling L; Fleetwood G; Stone D; Darley-Usmar V
Atherosclerosis; 1996 Jan; 119(2):169-79. PubMed ID: 8808494
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of VCAM-1 expression in the arterial wall is shared by structurally different antioxidants that reduce early atherosclerosis in NZW rabbits.
Fruebis J; Silvestre M; Shelton D; Napoli C; Palinski W
J Lipid Res; 1999 Nov; 40(11):1958-66. PubMed ID: 10552999
[TBL] [Abstract][Full Text] [Related]
3. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
Kleinveld HA; Demacker PN; Stalenhoef AF
Arterioscler Thromb; 1994 Aug; 14(8):1386-91. PubMed ID: 8049202
[TBL] [Abstract][Full Text] [Related]
4. The influence of magnesium-pyridoxal-5'-phosphate-glutamate in comparison with probucol, alpha-tocopherol and trolox on copper-induced oxidation of human low density lipoprotein in vitro.
Kögl C; Schneider W; Elstner EF
Biochem Pharmacol; 1994 Jun; 47(12):2201-6. PubMed ID: 8031313
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of probucol versus vitamin E on ex vivo oxidation susceptibility of lipoproteins in hyperlipoproteinemia.
Dujovne CA; Harris WS; Gerrond LL; Fan J; Muzio F
Am J Cardiol; 1994 Jul; 74(1):38-42. PubMed ID: 8017303
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of alpha-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbits.
Bräsen JH; Koenig K; Bach H; Kontush A; Heinle H; Witting PK; Ylä-Herttuala S; Stocker R; Beisiegel U
Atherosclerosis; 2002 Aug; 163(2):249-59. PubMed ID: 12052471
[TBL] [Abstract][Full Text] [Related]
7. Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza.
Wu YJ; Hong CY; Lin SJ; Wu P; Shiao MS
Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):481-6. PubMed ID: 9514418
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women.
Bhavnani BR; Cecutti A; Gerulath A; Woolever AC; Berco M
Menopause; 2001; 8(6):408-19. PubMed ID: 11723413
[TBL] [Abstract][Full Text] [Related]
9. The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters.
El-Swefy S; Schaefer EJ; Seman LJ; van Dongen D; Sevanian A; Smith DE; Ordovas JM; El-Sweidy M; Meydani M
Atherosclerosis; 2000 Apr; 149(2):277-86. PubMed ID: 10729377
[TBL] [Abstract][Full Text] [Related]
10. The effect of pharmacological doses of different antioxidants on oxidation parameters and atherogenesis in hyperlipidaemic rabbits.
Djahansouzi S; Braesen JH; Koenig K; Beisiegel U; Kontush A
Atherosclerosis; 2001 Feb; 154(2):387-98. PubMed ID: 11166771
[TBL] [Abstract][Full Text] [Related]
11. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis.
Lee HS; Jeong JY; Kim BC; Kim YS; Zhang YZ; Chung HK
Kidney Int; 1997 Apr; 51(4):1151-9. PubMed ID: 9083281
[TBL] [Abstract][Full Text] [Related]
12. Effect of the antioxidant probucol on transplant arteriosclerosis in aorta-allografted rabbits.
Andersen HO; Holm P; Nordestgaard BG; Hansen BF; Kjeldsen K; Elinder LS; Stender S
J Mol Cell Cardiol; 1995 Aug; 27(8):1561-71. PubMed ID: 8523419
[TBL] [Abstract][Full Text] [Related]
13. Vitamin E combined with selenium inhibits atherosclerosis in hypercholesterolemic rabbits independently of effects on plasma cholesterol concentrations.
Schwenke DC; Behr SR
Circ Res; 1998 Aug; 83(4):366-77. PubMed ID: 9721693
[TBL] [Abstract][Full Text] [Related]
14. Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice.
Maor I; Hayek T; Coleman R; Aviram M
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2995-3005. PubMed ID: 9409286
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of a novel water-soluble vitamin E derivative on atherosclerosis in rabbits.
Yoshida N; Murase H; Kunieda T; Toyokuni S; Tanaka T; Terao J; Naito Y; Tanigawa T; Yoshikawa T
Atherosclerosis; 2002 May; 162(1):111-7. PubMed ID: 11947904
[TBL] [Abstract][Full Text] [Related]
16. Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants.
Fruebis J; Bird DA; Pattison J; Palinski W
J Lipid Res; 1997 Dec; 38(12):2455-64. PubMed ID: 9458269
[TBL] [Abstract][Full Text] [Related]
17. The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881.
Feldman DL; Mogelesky TC; Sharif R; Sawyer WK; Jeune M; Hu CW; Leonards KS; Prescott MF
Atherosclerosis; 1999 Jun; 144(2):343-55. PubMed ID: 10407495
[TBL] [Abstract][Full Text] [Related]
18. Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice.
Bird DA; Tangirala RK; Fruebis J; Steinberg D; Witztum JL; Palinski W
J Lipid Res; 1998 May; 39(5):1079-90. PubMed ID: 9610776
[TBL] [Abstract][Full Text] [Related]
19. S 12340: a potent inhibitor of the oxidative modification of low-density lipoprotein in vitro and ex vivo in WHHL rabbits.
Breugnot C; Privat S; Guillonneau C; Regnier G; Bouzom F; Vilaine JP; Lenaers A
J Pharmacol Exp Ther; 1994 May; 269(2):515-20. PubMed ID: 8182520
[TBL] [Abstract][Full Text] [Related]
20. Increased oxidation resistance of atherogenic plasma lipoproteins at high vitamin E levels in non-vitamin E supplemented men.
Porkkala-Sarataho E; Nyyssönen K; Salonen JT
Atherosclerosis; 1996 Jul; 124(1):83-94. PubMed ID: 8800496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
